CGTX
insider transactionsCOGNITION THERAPEUTICS INC — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Cluster buy signal: Multiple insiders at the same company buying around the same time — often a stronger signal than a single buy. 3 different insiders made open-market purchases in the last 365 days, totalling $32.5K.
Net shares · 365d
+29.2K
29.2K buy · 0 sell
Net value · 365d
$32.5K
$32.5K in · $0 out
Sentiment · 365d
Net buying
100% buying · 0% selling
Open-market trades · 365d
3
29.2K buy · 0 sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
Transactions · 365d
-
Grant·A
Director
$0
25.0K sh
Own +52%
-
Grant·A
Director
$0
25.0K sh
Own +52%
-
Grant·A
Director
$0
25.0K sh
Own +29%
-
Grant·A
Director
$0
25.0K sh
Own +43%
-
Grant·A
Director, 10% Owner
$0
25.0K sh
Own +44%
-
Other·F
Chief Financial Officer
$11.0K
8.6K sh · $1.28
Own -1%
-
Buy·P
Chief Financial Officer
$11.3K
10.0K sh · $1.13
Own +2%
-
Buy·P
Ricciardi Lisa KEY
CEO & President
$10.1K
9.2K sh · $1.10
Own +1%
-
Buy·P
Chief Medical Officer
$11.1K
10.0K sh · $1.11
Own +1%
-
Other·F
Ricciardi Lisa KEY
CEO & President
$6.6K
5.8K sh · $1.12
Own -0%
-
Other·F
Chief Medical Officer
$5.2K
4.7K sh · $1.12
Own -1%
-
Other·F
Chief Financial Officer
$1.7K
1.6K sh · $1.12
Own -0%
-
Other·F
Chief Medical Officer
$40.6K
38.4K sh · $1.06 avg · 2 lots
Own -4%
-
Other·F
Chief Financial Officer
$27.7K
26.9K sh · $1.03
Own -4%
-
Other·F
Ricciardi Lisa KEY
CEO & President
$82.4K
77.7K sh · $1.06 avg · 2 lots
Own -4%
-
Grant·A
Chief Medical Officer
$0
400.0K sh
Own +79%
-
Grant·A
Chief Financial Officer
$0
200.0K sh
Own +45%
-
Grant·A
Ricciardi Lisa KEY
CEO & President
$0
800.0K sh
Own +81%
-
Grant·A
Chief Financial Officer
$0
30.0K sh
Own +7%
-
Other·F
Chief Financial Officer
$14.0K
9.4K sh · $1.50
Own -2%
-
Grant·A
Chief Medical Officer
$0
65.0K sh
Own +14%
-
Other·F
Chief Medical Officer
$30.4K
20.3K sh · $1.50
Own -4%
-
Grant·A
Ricciardi Lisa KEY
CEO & President
$0
75.0K sh
Own +8%
-
Other·F
Ricciardi Lisa KEY
CEO & President
$35.1K
23.4K sh · $1.50
Own -2%
-
Exercise·M
Director,TenPercentOwner
$0
7.7K sh
Own New
-
Exercise·M
Director,TenPercentOwner
$6.5K
7.7K sh · $0.84
Own +16%
-
Other·F
Ricciardi Lisa KEY
CEO & President
$15.7K
23.4K sh · $0.67
Own -2%
-
Grant·A
Ricciardi Lisa KEY
CEO & President
$0
75.0K sh
Own +8%
-
Grant·A
Chief Medical Officer
$0
65.0K sh
Own +16%
-
Other·F
Chief Medical Officer
$13.6K
20.3K sh · $0.67
Own -4%
-
Other·F
Chief Financial Officer
$6.3K
9.4K sh · $0.67
Own -2%
-
Grant·A
Chief Financial Officer
$0
30.0K sh
Own +7%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 17, 2026 | Khattar Jack A. | Grant A | 25.0K | $0 |
| Jun 17, 2026 | Monia Brett P | Grant A | 25.0K | $0 |
| Jun 17, 2026 | Wallace Peggy | Grant A | 25.0K | $0 |
| Jun 17, 2026 | RICHSTONE ELLEN B | Grant A | 25.0K | $0 |
| Jun 17, 2026 | Fletcher Aaron G.L. | Grant A | 25.0K | $0 |
| May 1, 2026 | Doyle John Brendan KEY | Other F | 8.6K | $11.0K |
| Apr 16, 2026 | Doyle John Brendan KEY | Buy P | 10.0K | $11.3K |
| Apr 16, 2026 | Ricciardi Lisa KEY | Buy P | 9.2K | $10.1K |
| Apr 16, 2026 | Caggiano Anthony | Buy P | 10.0K | $11.1K |
| Feb 15, 2026 | Ricciardi Lisa KEY | Other F | 5.8K | $6.6K |
| Feb 15, 2026 | Caggiano Anthony | Other F | 4.7K | $5.2K |
| Feb 15, 2026 | Doyle John Brendan KEY | Other F | 1.6K | $1.7K |
| Feb 4, 2026 | Caggiano Anthony | Other F | 38.4K2 lots | $40.6K |
| Feb 4, 2026 | Doyle John Brendan KEY | Other F | 26.9K | $27.7K |
| Feb 4, 2026 | Ricciardi Lisa KEY | Other F | 77.7K2 lots | $82.4K |
| Feb 3, 2026 | Caggiano Anthony | Grant A | 400.0K | $0 |
| Feb 3, 2026 | Doyle John Brendan KEY | Grant A | 200.0K | $0 |
| Feb 3, 2026 | Ricciardi Lisa KEY | Grant A | 800.0K | $0 |
| Dec 18, 2025 | Doyle John Brendan KEY | Grant A | 30.0K | $0 |
| Dec 18, 2025 | Doyle John Brendan KEY | Other F | 9.4K | $14.0K |
| Dec 18, 2025 | Caggiano Anthony | Grant A | 65.0K | $0 |
| Dec 18, 2025 | Caggiano Anthony | Other F | 20.3K | $30.4K |
| Dec 18, 2025 | Ricciardi Lisa KEY | Grant A | 75.0K | $0 |
| Dec 18, 2025 | Ricciardi Lisa KEY | Other F | 23.4K | $35.1K |
| Sep 19, 2025 | Fletcher Aaron G.L. | Exercise M | 7.7K | $0 |
| Sep 19, 2025 | Fletcher Aaron G.L. | Exercise M | 7.7K | $6.5K |
| Jul 29, 2025 | Ricciardi Lisa KEY | Other F | 23.4K | $15.7K |
| Jul 29, 2025 | Ricciardi Lisa KEY | Grant A | 75.0K | $0 |
| Jul 29, 2025 | Caggiano Anthony | Grant A | 65.0K | $0 |
| Jul 29, 2025 | Caggiano Anthony | Other F | 20.3K | $13.6K |
| Jul 29, 2025 | Doyle John Brendan KEY | Other F | 9.4K | $6.3K |
| Jul 29, 2025 | Doyle John Brendan KEY | Grant A | 30.0K | $0 |
Buy Sell Non-market (grant · exercise · gift)
About CGTX insider trading
This page tracks insider transactions for COGNITION THERAPEUTICS INC (CGTX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.